Alpha DNA Investment Management’s American Tower AMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200
Closed -$47K 130
2021
Q1
$47K Hold
200
0.05% 181
2020
Q4
$44K Buy
+200
New +$46.5K 0.05% 190

Other funds holding AMT

Alpha DNA Investment Management's AMT Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of American Tower (AMT) in Q2 2021, closing a stake of 200 shares — an estimated $47K sold.

Alpha DNA Investment Management first reported a position in AMT in Q4 2020 and held it in 2 quarters. The position peaked at $47K in Q1 2021. 1,649 funds tracked by Wall St. Rank hold AMT as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining American Tower position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 200 American Tower shares in Q2 2021, an estimated $47K.
  • Alpha DNA Investment Management first reported a position in American Tower in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's American Tower position peaked at $47K in Q1 2021.
  • 1,649 funds tracked by Wall St. Rank held American Tower as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.